首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1378695

寡核苷酸合成市場：依設備和服務、依技術、依核酸、依應用、依最終用戶、依地區

Oligonucleotide Synthesis Market,By Equipment and Services (Equipment/Synthesizer, Reagents, Services, ), By Technology, By Nucleic Acid, By Application, By End User, By Geography

出版日期: 2023年10月18日 | 出版商:

Coherent Market Insights | 英文 198 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2023 年，全球寡核苷酸合成市場將達到 38.1 億美元，並預計在預測期內（2023-2030 年）年複合成長率為 10.9%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	38.1億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	10.90%	2030年市場規模預測	78.7億美元

圖 1. 2023 年依設備和服務分類的寡核苷酸合成全球市場佔有率(%)

寡核苷酸療法徹底改變了製藥業。寡核苷酸療法是一類由短 RNA 或 DNA 鏈組成的藥物，可以在合成過程中進行修飾，以改變導致許多疾病的蛋白質的表達。

市場相關人員有興趣獲得監管機構的核准，預計這將在預測期內推動全球寡核苷酸合成市場的成長。例如，2021年，美國食品藥物管理局核准了Inclisiran。 Inclisiran 是由製藥公司諾華公司 (Novartis AG) 的子公司 Medicines Company 開發的，該公司已從美國生物製藥公司 Alnylam Pharmaceuticals 獲得了 inclisiran 的權利。 Inclisiran 是一種心血管疾病治療藥物，它顯示了寡核苷酸作為針對心血管疾病、腫瘤和代謝疾病等常見疾病的大量患者群體的治療方法的潛力。目前，不少廠商正在針對寡核苷酸藥物的開發進行研發。

市場動態

市場參與者正在從事收購等無機活動，以擴大基本客群。預計這將對預測期內全球寡核苷酸合成市場的成長產生正面影響。例如，2021年1月，英國階段生物技術公司Sixfold Bioscience與多學科計劃OLIGOMED宣布合作開發寡核苷酸療法。 Sixfold Biosciences 也將接收來自創新培訓網路 (ITN) 的博士生 Marie Sklodowska-Curie，她將參與階段研究 (ESR)，以改進 Sixfold 的體內寡核苷酸遞送技術。

本研究的主要特點

本報告詳細分析了全球寡核苷酸合成市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
本報告還闡明了各個區隔市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
本報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
本報告根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球寡核苷酸合成市場的主要企業。
該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
全球寡核苷酸合成市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球寡核苷酸合成市場的各種策略矩陣來促進他們的決策。

公司簡介
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Twist Bioscience
- STA Pharmaceutical Co. Ltd.
- KINOVATE LIFE SCIENCES
- CUSABIO TECHNOLOGY LLC
- Synbio Technologies
- GENEWIZ
- Agilent Technologies, Inc.
- Maravai LifeSciences Holdings, Inc.
- Biogen
- Eurofins Scientific
- Sarepta Therapeutics, Inc.
- LGC Limited
- Kaneka Corporation
- Biotage
- Nitto Denko Corporation

第12章章節

參考
調查方法

簡介目錄

Product Code: CMI4257

The global oligonucleotide synthesis market is estimated to be valued at US$ 3.81 Billion in 2023 and is expected to exhibit a CAGR of 10.9% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.81 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	10.90%	2030 Value Projection:	US$ 7.87 Bn

Figure 1. Global Oligonucleotide Synthesis Market Share (%), By Equipment and Services, 2023

Oligonucleotide therapeutics have revolutionized the pharmaceutical industry. They are a class of drugs and are composed of short strands of RNA or DNA that can be modified during synthesis in order to alter the expression of a number of disease-causing proteins.

Market players are interested in receiving approval from the regulatory authorities, and this is expected to drive the growth of the global oligonucleotide synthesis market over the forecast period. For instance, in the year 2021, the U.S. Food and Drug Administration approved Inclisiran. Inclisiran is being developed by the Medicines Company, a subsidiary of Novartis AG, a pharmaceutical company, which licensed the rights to inclisiran from Alnylam Pharmaceuticals, an American biopharmaceutical company. Inclisiran is indicated for the treatment of cardiovascular disease and thus demonstrates the opportunity oligonucleotides present as a treatment modality for large patient populations targeting a breadth of common diseases, including cardiovascular disease, oncology, and metabolic disorders. Currently, a number of manufacturers are conducting research and development activities for the development of oligonucleotide drugs.

Market Dynamics

Market players are engaged in conducting inorganic activities such as acquisitions in order to increase their customer base. This is expected to have a positive impact on the growth of the global oligonucleotide synthesis market over the forecast period. For instance, in January 2021, Sixfold Bioscience, a U.K.-based preclinical-stage biotechnology company, and OLIGOMED, a multidisciplinary project, announced a partnership to develop oligonucleotide therapeutics. Sixfold Bioscience also received funding from Marie Sklodowska-Curie, Innovative Training Network (ITN) to enroll PhD students in early-stage research (ESR) to improve Sixfold's in vivo oligonucleotide delivery technology.

Key features of the study:

This report provides an in-depth analysis of the global oligonucleotide synthesis market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global oligonucleotide synthesis market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Twist Bioscience, STA Pharmaceutical Co. Ltd., KINOVATE LIFE SCIENCES, CUSABIO TECHNOLOGY LLC, Synbio Technologies, GENEWIZ, Agilent Technologies, Inc., Maravai LifeSciences Holdings, Inc., Biogen, Eurofins Scientific, Sarepta Therapeutics, Inc., LGC Limited, Kaneka Corporation, Biotage and Nitto Denko Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global oligonucleotide synthesis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oligonucleotide synthesis market

Oligonucleotide Synthesis Market Detailed Segmentation:

By Equipment and Services:
- Nucleic Acid Synthesizer
- Peptide Synthesizer
- Oligo synthesis
- Modification
- Purification
- Equipment/Synthesizer
- Reagents
- Services
By Technology:
- Column-based
- Microarray-based
By Nucleic Acid:
- DNA
- RNA
By Application:
- Drug Discovery
- Therapeutics
By End User:
- Academic Research Institutes
- Diagnostic Laboratories
- Pharmaceutical-biotechnology Companies
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Company Profiles
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Twist Bioscience
- STA Pharmaceutical Co. Ltd.
- KINOVATE LIFE SCIENCES
- CUSABIO TECHNOLOGY LLC
- Synbio Technologies
- GENEWIZ
- Agilent Technologies, Inc.
- Maravai LifeSciences Holdings, Inc.
- Biogen
- Eurofins Scientific
- Sarepta Therapeutics, Inc.
- LGC Limited
- Kaneka Corporation
- Biotage
- Nitto Denko Corporation

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Equipment and Services
- Market Snippet, By Technology
- Market Snippet, By Nucleic Acid
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Recent Test Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Oligonucleotide Synthesis Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Oligonucleotide Synthesis Market, By Equipment and Services, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Equipment and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Nucleic Acid Synthesizer
- Peptide Synthesizer
Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
- Oligo Synthesis
- Modification
- Purification

6. Global Oligonucleotide Synthesis Market, By Technology, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
ColuBn-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Microarray-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Oligonucleotide Synthesis Market, By Nucleic Acid, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
DNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
RNA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

8. Global Oligonucleotide Synthesis Market, By Application, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Therapeutics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

9. Global Oligonucleotide Synthesis Market, By End User, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Academic Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Pharmaceutical-biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

10. Global Oligonucleotide Synthesis Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast,Y-o-Y Growth and By Equipment and Services, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Technology, 2018 -2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Nucleic Acid, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By Application, 2018-2030, (US$ Bn)
- Market Size and Forecast,Y-o-Y Growth and By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

11. Competitive Landscape

Company Profiles
- Thermo Fisher Scientific Inc.*
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Merck KGaA
- Danaher Corporation
- Twist Bioscience
- STA Pharmaceutical Co. Ltd.
- KINOVATE LIFE SCIENCES
- CUSABIO TECHNOLOGY LLC
- Synbio Technologies
- GENEWIZ
- Agilent Technologies, Inc.
- Maravai LifeSciences Holdings, Inc.
- Biogen
- Eurofins Scientific
- Sarepta Therapeutics, Inc.
- LGC Limited
- Kaneka Corporation
- Biotage
- Nitto Denko Corporation